CompuGroup Medical SE & Co. KGaA (ETR: COP)

ETR: COP Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,189	1,228	1,175	1,063	869.13	770.38
Other Revenue	0.11	0.11	0.25	0.08	0.08	0.05
Revenue	1,189	1,228	1,175	1,063	869.21	770.43
Revenue Growth (YoY)	-4.63%	4.52%	10.55%	22.26%	12.82%	4.73%
Cost of Revenue	808.71	813.16	763.1	689.15	533.23	478.4
Gross Profit	380.68	414.75	411.71	373.55	335.98	292.03
Selling, General & Admin	11.85	11.85	11.63	10.78	8.82	6.76
Other Operating Expenses	155.74	164.46	179.32	144.21	126.97	103.68
Operating Expenses	286.4	292.65	313.14	266.92	215.79	176.08
Operating Income	94.28	122.1	98.56	106.63	120.19	115.95
Interest Expense	-30.33	-24.32	-9.12	-5.4	-5.3	-5.68
Interest & Investment Income	1.77	1.06	0.81	0.72	1.52	1.05
Earnings From Equity Investments	0.62	0.62	-0.1	0.03	-0.93	-1.79
Currency Exchange Gain (Loss)	-2.94	-2.94	1.08	-0.39	-4.27	0.17
Other Non Operating Income (Expenses)	-14.63	-14.63	17.27	0.74	-0.92	-0.29
EBT Excluding Unusual Items	48.77	81.89	108.51	102.34	110.29	109.42
Impairment of Goodwill	-	-	-	-	-	-1.25
Gain (Loss) on Sale of Assets	1.04	1.04	0.16	1.69	0.14	-0.43
Asset Writedown	-11.45	-11.45	-0.34	-6.15	-	-
Other Unusual Items	1.2	1.2	-1.51	0	-	-
Pretax Income	39.55	72.67	106.82	97.87	110.43	107.75
Income Tax Expense	14.24	25.8	32.7	28.84	37.01	41.59
Earnings From Continuing Operations	25.31	46.87	74.12	69.03	73.42	66.15
Net Income to Company	25.31	46.87	74.12	69.03	73.42	66.15
Minority Interest in Earnings	-0.15	-0.96	-0.71	-0.06	-0.23	-0.33
Net Income	25.17	45.92	73.41	68.97	73.19	65.82
Net Income to Common	25.17	45.92	73.41	68.97	73.19	65.82
Net Income Growth	-66.72%	-37.45%	6.44%	-5.77%	11.20%	-31.50%
Shares Outstanding (Basic)	52	52	52	53	51	49
Shares Outstanding (Diluted)	52	52	52	53	52	49
Shares Change (YoY)	0.09%	0.32%	-1.29%	1.15%	5.96%	-1.04%
EPS (Basic)	0.48	0.88	1.41	1.30	1.43	1.35
EPS (Diluted)	0.48	0.88	1.40	1.30	1.40	1.33
EPS Growth	-66.39%	-37.21%	7.69%	-7.14%	5.26%	-30.73%
Free Cash Flow	123.09	160.56	119.18	138.23	132.25	95.81
Free Cash Flow Per Share	2.35	3.06	2.28	2.61	2.53	1.94
Dividend Per Share	1.000	1.000	0.500	0.500	0.500	0.500
Dividend Growth	100.00%	100.00%	0%	0%	0%	0%
Gross Margin	32.01%	33.78%	35.04%	35.15%	38.65%	37.90%
Operating Margin	7.93%	9.94%	8.39%	10.03%	13.83%	15.05%
Profit Margin	2.12%	3.74%	6.25%	6.49%	8.42%	8.54%
Free Cash Flow Margin	10.35%	13.08%	10.14%	13.01%	15.21%	12.44%
EBITDA	144.56	169.24	151.77	160.91	158.65	144.02
EBITDA Margin	12.15%	13.78%	12.92%	15.14%	18.25%	18.69%
D&A For EBITDA	50.28	47.15	53.2	54.28	38.46	28.07
EBIT	94.28	122.1	98.56	106.63	120.19	115.95
EBIT Margin	7.93%	9.94%	8.39%	10.03%	13.83%	15.05%
Effective Tax Rate	36.00%	35.50%	30.61%	29.47%	33.51%	38.60%

Source: S&P Capital IQ. Standard template. Financial Sources.